Updated:
Marie Curie
Marie Curie provides palliative care services, hospice care, and support for individuals and families affected by terminal illnesses. The organization conducts...
Marie Curie
Marie Curie provides palliative care services, hospice care, and support for individuals and families affected by terminal illnesses. The organization conducts research and advocacy to improve end-of-life care. Founded in 1948, Marie Curie is based in London, United Kingdom.
General information
Firm type
Endowment / Foundation
Year founded
1948
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Additional offices
Belfast, Northern Ireland · Bradford, England · Penarth, Wales · Edinburgh, Scotland · Glasgow, Scotland · Liverpool, England · Newcastle, England · Solihull, England
Principals
Kevin Parry
Chair of the Board of Trustees
Matthew Reed
Chief Executive Officer
HM King Charles III
Royal Patron
Sector focus
Frequently asked questions
How is Marie Curie's investment portfolio governed?
The investment portfolio is overseen by an independent board of trustees, chaired by Kevin Parry as of January 2025. Day-to-day investment decisions are delegated to professional managers under an investment policy that prioritizes income generation and capital preservation. The charity's Royal Patron, HM King Charles III, holds a ceremonial role without fiduciary authority.
What is the relationship between Marie Curie's retail operation and its clinical work?
The 170-shop retail portfolio generates unrestricted income that funds the charity's core palliative care mission, operating as a separate commercial entity. This structure buffers clinical delivery from investment portfolio volatility — hospice nursing is not funded by endowment drawdowns alone but by a diversified revenue mix that includes high-street retail, corporate partnerships with Superdrug and Morrisons, and fundraising.
Does Marie Curie invest directly in healthcare-related assets?
Its primary healthcare assets are the nine hospices and nursing infrastructure it owns and operates directly — not private equity stakes in healthcare companies. The investment portfolio holds traditional asset classes (equities, fixed income, property) and does not pursue venture or impact investing in health-tech startups, consistent with a mandate centered on near-term income generation rather than thematic allocation.
How does Marie Curie differ from a typical endowed foundation?
Unlike university endowments that invest for perpetual growth, Marie Curie's investment mandate is income-oriented: the charity exists to fund ongoing care, not to compound in perpetuity. The retail estate, corporate partnerships, and fundraising all supplement investment income, making the charity less dependent on capital-market returns than a grant-making foundation would be.
Who runs investment decisions at Marie Curie?
The Board of Trustees holds ultimate fiduciary responsibility, and investment management is outsourced to external managers operating under a conservative mandate. The charity does not maintain an in-house chief investment officer or internal investment team — a structural choice that reflects its focus on care delivery rather than portfolio construction.
What geographic regions does Marie Curie's portfolio cover?
Its physical assets are concentrated in the United Kingdom, with nine hospice facilities spanning all four UK nations — England, Scotland, Wales, and Northern Ireland. The liquid investment portfolio includes global equities and fixed income, but the charity's operational footprint is exclusively domestic, reflecting its NHS-adjacent role in UK end-of-life care.
Is Marie Curie's investment posture influenced by its charitable status?
Yes. As a UK registered charity, its investment policy is constrained by Charity Commission guidance requiring trustees to prioritize the charity's purposes over financial return maximization. This produces a conservative asset allocation — income-generating assets dominate, speculative positions are avoided, and ethical exclusions are applied — making the portfolio structurally distinct from unconstrained allocators.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: